Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rimexolone | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Corneal staining; dry eye sympton | Immediate |
| Measure | Description | Time Frame |
|---|---|---|
| Corneal staining; dry eye sympton | Prolonged |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael Brubaker, PhD | Alcon Research | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cleveland | Cleveland | Ohio | 44115 | United States |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C013769 | rimexolone |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided